Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-07
1999-11-16
Campell, Bruce R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
4353201, A01N 4304, C12N 1500
Patent
active
059858460
ABSTRACT:
A gene transfer vector comprising adenovirus inverted terminal repeats, recombinant adenovirus particles containing the same, a method for producing the same and a method of use of the same to introduce and express a foreign gene in eukaryotic cells, and to treat muscular dystrophy, is disclosed.
REFERENCES:
patent: 5670488 (1997-09-01), Gregory et al.
Mitani et al, "Rescue, Propagation, and Partial Purification of a Helper Virus-Dependent Adenovirus Vector", Proc. Natl. Acad. Sci. USA, 92:3854-3858 (1995).
Deuring et al, "An Unusual Symmetric Recombinant Between Adenovirus Type 12 DNA and Human Cell DNA", Proc. Natl. Acad. Sci. USA, 78(5):3142-3146 (1981).
Gilardi et al. Expression of human alpha-1-antitrypsin using a recombinant adenovirus vector. FEBS Letters, vol. 267, No. 1, pp. 60-62, Jul. 1990.
Berkner, K. L. Development of Adenovirus Vectors for the Expression of Heterologous Genes. Biotechniques. vol. 6, No. 7, pp. 616-629, 1988.
Karpati et al., Clin. Invest. Med., 17(5), 1994, 499-509.
Amalfitano et al., Am. J. Human Genetics, 57 (4 supp) 1995, A234.
Marshall, Science, 269, 1995, 1050-1055.
Miller et al., FASEB J., 9, 1995, 190-199.
Culver et al., TIG, 1994, 10(5), 174-178.
Hodgson, Exp. Op. Ther. Pat., 5(5), 1995, 459-468.
Caskey C. Thomas
Clemens Paula R.
Kochanek Stefan
Mitani Kohnosuke
Baylor College of Medicine
Campell Bruce R.
Clark Deborah J. R.
Howard Hughes Medical Institute
LandOfFree
Gene therapy for muscular dystrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene therapy for muscular dystrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene therapy for muscular dystrophy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1324829